FdaApplication
ANDA 217761
Identifiers
- fda_app_no: ANDA217761
Properties
| Property | Value |
|---|---|
| applicant_name | ANNORA PHARMA PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2025-07-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SPIRONOLACTONE | SPIRONOLACTONE | 100MG | TABLET;ORAL |
| SPIRONOLACTONE | SPIRONOLACTONE | 50MG | TABLET;ORAL |
| SPIRONOLACTONE | SPIRONOLACTONE | 25MG | TABLET;ORAL |
3 products